Delequamine manufacturers
- Delequamine
-
- $258.00
-
2026-07-14
- CAS:119905-05-4
- Purity: 99.96%
- Supply Ability: 10g
|
| | Delequamine Basic information |
| Product Name: | Delequamine | | Synonyms: | Delequamine;(8aR)-3-Methoxy-12-(methylsulfonyl)-5,8,8aα,9,10,11,12,12aα,13,13aα-decahydro-6H-isoquino[2,1-g][1,6]naphthyridine;(8aR)-5,8,8aα,9,10,11,12,12aα,13,13aα-Decahydro-12-(methylsulfonyl)-3-methoxy-6H-isoquino[2,1-g][1,6]naphthyridine;RS-15385-197;RS-42206;Delequamine [inn];6H-Isoquino[2,1-g][1,6]naphthyridine, 5,8,8a,9,10,11,12,12a,13,13a-decahydro-3-methoxy-12-(methylsulfonyl)-, (8aR,12aS,13aS)- | | CAS: | 119905-05-4 | | MF: | C18H26N2O3S | | MW: | 350.48 | | EINECS: | | | Product Categories: | | | Mol File: | 119905-05-4.mol |  |
| | Delequamine Chemical Properties |
| Boiling point | 507.476±60.00 °C(Press: 760.00 Torr)(predicted) | | density | 1.300±0.10 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | pka | 7.696±0.20(predicted) |
| | Delequamine Usage And Synthesis |
| Uses | Impotence therapy adjunct. | | in vivo | Delequamine (0.4-6.4 mg/kg; oral, single dose) can increase the sexual behavior score in a dose-dependent manner in a model where untrained male rats are exposed to estrogen-progesterone-treated, sexually receptive female rats. Furthermore, the combination of Delequamine (0.4 mg/kg; oral, single dose) and 8-OH-DPAT (HY-112061) (0.1 mg/kg; subcutaneous injection) can increase the percentage of mounts, intromissions, and ejaculations in rats, shorten the ejaculation latency, and reduce the number of intromissions[1]. | | IC 50 | α2-adrenergic receptor: 9.5 (pKi); α1-adrenergic receptor: 5.3 (pKi) |
| | Delequamine Preparation Products And Raw materials |
|